ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 752703 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 752703; 2) Community: the network communities that were significantly associated with the response to NSC 752703; 3) Molecule: the relationships between components within communities and NSC 752703; 4) MDR: the compounds that were significantly associated with the NSC 752703.

NSC Compound Enrichment Correlation
NSC 732317 6,7-dichloro-2-methyl-3-(phenylthio)quinoxaline 1,4-dioxide 0.0459335986102865 0.19423433
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.0459335986102865 0.24917157
NSC 744658 6-(p-toluenesulfonylaminoethyl)diquino-1,4-thiazine 0.0459335986102865 -0.058449714
NSC 756698 Clomiphene citrate (USAN) 0.0459335986102865 0.19337568
NSC 758664 Sirolimus [USAN] 0.0459335986102865 -0.077523373
NSC 758682 ARTENIMOL 0.0459335986102865 0.34672173
NSC 759216 (3-(4-bromophenyl)-5-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydropyrazol-1-yl)(4-methoxyphenyl)methanone 0.0459335986102865 0.037277317
NSC 359466 Null 0.0474314077111082 0.33506745
NSC 144153 Datiscoside 0.048939380959983 0.026551851
NSC 172614 9H-Purin-2-amine, 9-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.048939380959983 0.35480187
Total:90  Current:87    [First] [Prev] [Next] [Last]